Abstract |
Autologous stem cell transplantation (ASCT) is a new treatment option in patients with systemic AL amyloidosis (AL). The purpose of this review is to summarize the clinical experience of ASCT for AL, and to discuss the feasibility and the future developments of this new approach.
|
Authors | P Moreau |
Journal | Leukemia
(Leukemia)
Vol. 13
Issue 12
Pg. 1929-31
(Dec 1999)
ISSN: 0887-6924 [Print] England |
PMID | 10602412
(Publication Type: Journal Article, Review)
|
Topics |
- Amyloidosis
(therapy)
- Hematopoietic Stem Cell Transplantation
- Humans
- Transplantation Conditioning
- Transplantation, Autologous
|